The General Objective of This Study is to Monitor, Assess, and Prevent the Potential Medication Errors Among Inpatients in the Tertiary Healthcare Facility of Nepal. This Study Aims to Develop and Implement the Medication Errors Reporting System in Hospital Settings.

NCT07002606 | Not Yet Recruiting DMC

• 2 other identifiers: 147/24PhD- 80/8 t-HS-04
• Study Type: observational
• Target: 62
• Locations: 0 countries
• Sites: N/A

Brief Summary

The goal of this observational study is to develop and implement Medication errors reporting system using the error reporting guidelines. The main question it aims to answer is: "Does development and implementation of Medication errors reporting guideline will help to reduce the errors rate and improve the patient safety?"

Conditions

Prescription With Medication Errors

Keywords

Medication errors; Mixed method study; tertiary healthcare facility

Outcome Measures

Primary Outcomes (1)

• reduction in Mediation error rate

  The newly developed Medication errors reporting guidelines will be implemented and will be used to evaluate the reduction in medication errors incident rates.

  6 months after the implementation of the Medication errors reporting guidelines

Interventions

medication errors reporting guidelines OTHER

the intervention is designed to reduce the medication errors and develop the culture of reporting the Medication errors in clinical settings.

Eligibility Criteria

• Sex: all
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Healthcare professionals including Doctors, Nurses and Pharmacist who are working in Dhulikhel Hospital.

You may not qualify if:

• The healthcare persons who accepted the consent but couldn't complete the survey will be excluded from the study.

Sponsors & Collaborators

• Kathmandu University School of Medical Sciences: lead

Study Officials

• Dr. Sony Shakya Professor in Pharmacology, PhD

  Kathmandu University School of Medical Science

  STUDY DIRECTOR

Central Study Contacts

Rudip Thapa Assistant Professor, M.Sc. (Medical) Pharmacology

CONTACT

+9779851218678; thaparudip@student.kusms.edu.np

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant Professor (Pharmacology)

Study Record Dates

• First Submitted: May 25, 2025
• First Posted: June 3, 2025
• Study Start: July 1, 2025
• Primary Completion: April 1, 2026
• Study Completion (Estimated): April 1, 2027
• Last Updated: June 3, 2025

Record last verified: 2025-05

Data Sharing

• IPD Sharing: Will not share